IL-4/IL-13 receptor modulator (Allostera)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-4/IL-13 receptor modulator (Allostera)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin 13 receptor modulatorsInterleukin-4 receptors modulators
TargetsInterleukin 13 receptorInterleukin-4 receptors
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllostera Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllostera Pharma
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A